Polomar Health Services, Inc.
PMHS
$0.80
$0.60295.99%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -36.73% | -62.07% | -66.91% | 20.81% | -54.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.73% | -62.07% | -66.91% | 20.81% | -54.42% |
| Cost of Revenue | 80.00% | -61.90% | -87.16% | 436.36% | -33.33% |
| Gross Profit | -51.69% | -63.11% | 18.52% | -39.74% | -55.28% |
| SG&A Expenses | 136.23% | 182.19% | 156.50% | 537.04% | 73.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 136.06% | 177.19% | 141.24% | 535.06% | 72.33% |
| Operating Income | -142.59% | -195.39% | -158.82% | -629.21% | -92.43% |
| Income Before Tax | -139.51% | -217.57% | -184.67% | -252.01% | -57.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -139.51% | -217.57% | -184.67% | -252.01% | -57.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -139.51% | -217.57% | -184.67% | -252.01% | -57.55% |
| EBIT | -142.59% | -195.39% | -158.82% | -629.21% | -92.43% |
| EBITDA | -44.41% | -60.87% | 1.08% | -- | -- |
| EPS Basic | -136.73% | -217.39% | -184.48% | -173.68% | -58.06% |
| Normalized Basic EPS | -137.70% | -218.60% | -186.11% | -174.58% | -56.41% |
| EPS Diluted | -136.73% | -217.39% | -184.48% | -189.47% | -58.06% |
| Normalized Diluted EPS | -137.70% | -218.60% | -186.11% | -174.58% | -56.41% |
| Average Basic Shares Outstanding | 1.27% | 0.04% | 0.01% | 28.73% | 0.00% |
| Average Diluted Shares Outstanding | 1.27% | 0.04% | 0.01% | 28.73% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |